Kyle Jenne
EVP, Chf GL Pdt Str Ofcr at Ionis Pharmaceuticals Inc (IONS) since February 2024
Kyle Jenne has filed 9 insider reports with the SEC since March 2024, as EVP and chf GL Pdt Str Ofcr at Ionis Pharmaceuticals Inc (IONS). In the last 12 months Kyle Jenne sold $507K of stock on the open market. In the latest filing, on April 17, 2026, Kyle Jenne sold 4,902 shares of Ionis Pharmaceuticals Inc (IONS) for $368K at an average of $75.17.
- Filings
- 9
- Companies
- 1
- Bought on market
- None
- Sold on market
- $592K
Companies where Kyle Jenne is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| EVP, Chf GL Pdt Str Ofcrsince February 2024 | 23,713 | $592K | $26.58 | Apr 17, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Apr 16, 2026-$368KIONSSEC Form 4 filed by Jenne KyleForm 4Exercise or conversion of a derivativeOpen-market sale
- Jan 16, 2026-$138KIONSEVP, Chf GL Pdt Str Ofcr Jenne Kyle sold $138,475 worth of shares (1,823 units at $75.96) and converted options into 7,013 shares, increasing direct ownership by 46% to 16,389 unitsForm 4Grant or awardExercise or conversion of a derivativeOpen-market sale
- Jan 16, 2026~$139KIONSKyle Jenne plans to sell 1,823 shares (~$139K)Form 144Planned sale
- Jan 2, 2026IONSSEC Form 4 filed by EVP, Chf GL Pdt Str Ofcr Jenne KyleForm 4Grant or award
- Apr 16, 2025-$85.5KIONSEVP, Chf GL Pdt Str Ofcr Jenne Kyle sold $85,534 worth of shares (3,016 units at $28.36) and converted options into 12,226 shares, increasing direct ownership by 463% to 11,199 unitsForm 4Exercise or conversion of a derivativeOpen-market sale
- Jan 15, 2025IONSSEC Form 4 filed by EVP, Chf GL Pdt Str Ofcr Jenne KyleForm 4Grant or award
- Jan 2, 2025IONSSEC Form 4 filed by EVP, Chf GL Pdt Str Ofcr Jenne KyleForm 4Grant or award
- Feb 26, 2024IONSSEC Form 4 filed by Jenne KyleForm 4Grant or award
Compare Kyle Jenne with
- Kyle Jenne vs Michael R Hayden1 shared
- Kyle Jenne vs C Frank Bennett1 shared
- Kyle Jenne vs Brett P Monia1 shared
- Kyle Jenne vs Patrick R. O'Neil1 shared
- Kyle Jenne vs Brian Birchler1 shared
- Kyle Jenne vs Peter N Reikes1 shared
Other insiders at the same companies
- Michael R HaydenIONS
- C Frank BennettIONS
- Brian BirchlerIONS
- Brett P MoniaIONS
- Patrick R. O'NeilIONS
- Peter N ReikesIONS
- Ludwig HantsonIONS
- Joan E HermanIONS
- Spencer R BerthelsenIONS
- Allene M. DiazIONS
- Holly B. KordasiewiczIONS
- Michael J. YangIONS
- Joseph LoscalzoIONS
- Joseph Klein IIIIONS
- Joseph BaroldiIONS
- Eugene SchneiderIONS
Questions about Kyle Jenne
- What is Kyle Jenne's role at Ionis Pharmaceuticals Inc?
- Kyle Jenne reports to the SEC as EVP and chf GL Pdt Str Ofcr at Ionis Pharmaceuticals Inc (IONS), according to the latest filing on April 17, 2026.
- How many shares does Kyle Jenne own?
- After the latest filing that states it, Kyle Jenne directly owned 23,713 shares of Ionis Pharmaceuticals Inc (IONS). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Kyle Jenne bought or sold stock recently?
- The most recent open-market sale was on April 16, 2026: sold 4,902 shares of Ionis Pharmaceuticals Inc (IONS) for $368K at an average of $75.17.
- How do I get alerts when Kyle Jenne files?
- Follow Kyle Jenne on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Kyle Jenne (SEC CIK 0001791857). Totals count each trade once, skipping amendments whose original is on file, from Mar 13, 2024 on. View on SEC EDGAR · Get this as JSON